Convexity Labs

HZO

Convexity Analyst · HZO
Buymedium confidenceTactical · no named thesis
Generated Jun 21, 2026

Analyst Note: HZO (MarineMax, Inc.)

Date: 2026-06-13 Event Date: 2026-06-13

1. Structural Readiness

Classification: CONFIRMED-ACTIVE

  • Conservative Entry: $33.34
  • Current Price: $34.95
  • Extension: +4.8% above conservative entry.
  • Volatility Context: The ATR at breakout was 5.0% (High), indicating strong structural quality and momentum at the time of the setup formation. Current ATR is 4.4% (High), suggesting the stock retains elevated volatility suitable for the "Small" cap bucket, though slightly compressed from the breakout point.

2. Thesis Layer

Thesis Classification: Tactical / Setup-Led Secular Exposure: None Named

As of 2026-06-13, there is no named secular thesis driving this specific setup. This is a tactical, setup-led name. The conviction must be derived strictly from the quality of the structural setup (the Coil formation) and the immediate business fundamentals disclosed in the most recent filings and earnings transcripts. We do not invent a macro thesis; we judge the name on its ability to execute its current operational plan and the technical confirmation of that execution via price action.

3. Business Overview

MarineMax, Inc. operates as the world's largest recreational boat and yacht retailer, marina operator, and superyacht services company. The business model is segmented into Retail Operations and Product Manufacturing.

  • Retail Operations: The company sells new and pre-owned recreational watercraft (pleasure boats, fishing boats, mega-yachts, etc.) and supplies marine parts, accessories, and service products. It also provides financing and insurance services to customers.
  • *Evidence:* As of the 2025-11-17 filing, new boat sales accounted for approximately 60.9% ($1.407 billion) of revenue in fiscal 2025. The company operates 79 retail locations across 21 U.S. states, with a heavy concentration in Florida (approx. 53-54% of dealership revenue).
  • *Evidence:* The company owns or operates over 65 marina and storage locations worldwide as of September 30, 2025, following the IGY acquisition and subsequent acquisitions of Treasure Island Marina and Shelter Bay Marina.
  • Product Manufacturing: The company manufactures and sells its own line of sport yachts and larger yachts.
  • *Evidence:* Sales of new Brunswick boats accounted for approximately 18% of revenue in fiscal 2025. Other key brands include Sea Ray (8%) and Boston Whaler (9%).
  • Financial Performance & Guidance:
  • *Evidence:* In the January 29, 2026 earnings transcript, management guided fiscal 2026 adjusted EBITDA to be in the range of $110 million to $125 million, with adjusted net income per diluted share expected between $0.40 and $0.95.
  • *Evidence:* Management reported a significant inventory reduction of nearly $170 million compared to the prior year, aiming to normalize supply chains.
  • *Evidence:* Same-store sales for fiscal 2026 are expected to finish flat to slightly positive, depending on product mix.

4. Archetype and Conviction

Archetype: Margin Inflector / Cyclical Recovery

This setup fits the Margin Inflector archetype. The company is transitioning from a period of inventory overhang and margin compression toward a normalized state where higher-margin businesses (marinas, finance, insurance, superyacht services) can drive consolidated profitability.

  • Margin Dynamics: Management explicitly noted in the Jan 29, 2026 transcript that gross margins were "more than 400 basis points below what would be considered a normal historical margin." However, they highlighted that higher-margin segments (marinas, F&I, superyacht services) are contributing favorably. The expectation is that as inventory levels improve in the second half of the fiscal year, margins will expand.
  • Balance Sheet Health: The company has improved its current ratio and total liabilities to tangible net worth ratio. Management stated they maintained a healthy net debt to adjusted EBITDA ratio of just over two times at quarter end.
  • Valuation Context: The financial spine indicates a forward consensus EPS of $0.73 for FY1 and $1.59 for FY2. The current price of $34.95 implies a forward P/E ratio that reflects the recovery in earnings, assuming the upper end of the guidance ($0.95) is achieved.
  • Conviction Stack:
  • *Thesis Strength:* Moderate (Tactical, no macro tailwinds named).
  • *Evidence Quality:* High (Recent earnings guidance, specific inventory reduction figures, clear balance sheet metrics).
  • *Rerating Potential:* Dependent on the realization of the "flat to slightly positive" same-store sales and the margin expansion from the 400 bps deficit.

5. Invalidations, Strengtheners, and Gaps

Invalidation:

  • A significant deterioration in the "flat to slightly positive" same-store sales guidance or a failure to maintain the net debt to EBITDA ratio near 2x would weaken the fundamental thesis.

Strengtheners:

  • Confirmation that inventory levels are improving meaningfully in the second half of the fiscal year as anticipated.
  • Evidence that the "larger product" segment is leading the recovery, as historically observed in past recoveries.
  • Sustained performance of the higher-margin marina and service businesses offsetting retail margin pressure.

Gaps in Evidence:

  • Tariff Impact: While management noted potential tariff actions on imports (E15), the specific quantitative impact on fiscal 2026 margins is not yet quantified in the provided evidence.
  • Interest Rate Sensitivity: Management acknowledged that higher long-term interest rates negatively impact customer willingness to purchase (E14), but the specific sensitivity of current demand to the prevailing rate environment in June 2026 is not detailed in the provided snippets.
  • Regional Concentration Risk: The heavy reliance on Florida (approx. 54% of revenue) presents a concentration risk that is noted but not mitigated by specific geographic diversification data in the current evidence.

PRIVATE ANALYST CALL

Judgment: Buy Confidence: medium Key risks: Persistent retail margin pressure and 400 bps below-normal gross margins; High concentration of revenue in Florida; Potential negative impact from tariffs and interest rates on customer demand. Sizing hint: Standard position sizing for a confirmed active coil in a small-cap sector; monitor ATR for volatility adjustments. Expected path: Management expects inventory improvement in H2 fiscal 2026 and flat-to-positive same-store sales; higher-margin service and marina businesses should continue to support consolidated gross profit as retail margins normalize. Expected horizon: 6 to 12 months, aligned with the realization of fiscal 2026 guidance and inventory normalization.

Loading chart...
Exhibit 1: HZO daily candlestick — no active setup overlay.

Source-backed evidence anchors and catalysts land once Convexity finishes coverage for HZO.

Core assumptions for this name haven't been articulated yet — they land alongside the rerating thesis.

Value picture unavailable — no financial spine on file for HZO.

Layer B fundamentals snapshot not yet available. Highlights land once Convexity finishes the classification.

Coverage: